Results 221 to 230 of about 4,075,451 (292)

Investigation of the Mechanism of Cinnamaldehyde in Irritable Bowel Syndrome Based via Network Pharmacology, Molecular Docking, and Animal Experiments

Pediatric Discovery, EarlyView.
Through network pharmacology and molecular docking, it has been discovered that CA can target MAOB, among other proteins, to exert a therapeutic effect in IBS. In vivo, CA lowered visceral hypersensitivity, anxiety and depression‐like behaviors, and fecal water content, highlighting its therapeutic potential for IBS via anti‐inflammatory pathways ...
Qingyang Yu, Boqing Xu, Chunfang Dai, Yayan Pang, Zhifang Dong   +4 more
wiley   +1 more source

Medication prescription patterns in cancer rehabilitation physiatry outpatients: A multicenter retrospective study

PM&R, EarlyView.
Abstract Background and Objective Previous work from this dataset found 45% prescribing frequency of any medications (35.1%, 33.5%, and 56.8% at institutions 1, 2, and 3 respectively), without significant difference between in‐person and telemedicine.
Matthew Chen, Nafis Eghrari, David Leong, Philip Chang, Jasmine Zheng, Amy Ng, Richard Wilson, Mary Vargo   +7 more
wiley   +1 more source

Mental Health Disorders in Pediatric Inflammatory Bowel Disease: Epidemiology, Mechanisms, and Interventions. [PDF]

J Inflamm Res
Liu Y, Hu Y, Zheng J, Wu Z.
europepmc   +1 more source

Polypharmacy among adolescents and adults with cerebral palsy in a clinical setting

PM&R, EarlyView.
Abstract Background Adolescents and adults with cerebral palsy often experience multimorbidity related to their condition, which primarily affects movement and posture but is also associated with pain, epilepsy, mood disorders, and other conditions. As such, these patients are often prescribed a range of medications to manage symptoms, thereby putting ...
Caitlin Cassidy, Joshua C. Wiener, Karen Pratt, Laura Brunton   +3 more
wiley   +1 more source

Pharmacological Assessment of <i>Calamus guruba</i> Methanolic Extract: Multitarget Effects on Diabetes, Inflammation, Anxiety, and Depression. [PDF]

Food Sci Nutr
Uddin M, Shorna TA, Suma KJ, Ekram MEH, Rana M, Mamun MJI.   +5 more
europepmc   +1 more source

Cognitive Mediation of Biopsychosocial Determinants of Quality of Life in Epilepsy. [PDF]

Psychol Res Behav Manag
Chen X, Zhou B, Liu Y, Sun L, Lu Z, Liu L, An S, Xie C, Jiang Y, Zhu C.   +9 more
europepmc   +1 more source

Pharmacology of oxazepam (Serax), a new anti-anxiety agent.

Current therapeutic research, clinical and experimental, 1966
openaire   +1 more source

Myasthenia gravis with dysphagia as the first symptom and misdiagnosed as anxiety-depressive state: a case report. [PDF]

Front Immunol
Aili K, Maimaiti M.
europepmc   +1 more source

Nutraceuticals and obsessive-compulsive disorder therapy. [PDF]

Adv Neurotoxicol
Mohammadi AH, Amin N, Tavousi SA, Mahabady MK, Aschner M, Mirzaei H.   +5 more
europepmc   +1 more source